Related references
Note: Only part of the references are listed.Quantitative assessment of HER2 amplification in HER2-positive breast cancer: its association with clinical outcomes
Qijia Xuan et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics
Carlos L. Arteaga et al.
CANCER CELL (2014)
Effect of p95HER2/611CTF on the Response to Trastuzumab and Chemotherapy
Josep Lluis Parra-Palau et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Targeted Therapy Resistance Mediated by Dynamic Regulation of Extrachromosomal Mutant EGFR DNA
David A. Nathanson et al.
SCIENCE (2014)
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells
Kristine Kleivi Sahlberg et al.
MOLECULAR ONCOLOGY (2013)
Gemcitabine Eliminates Double Minute Chromosomes from Human Ovarian Cancer Cells
Lisa Yu et al.
PLOS ONE (2013)
Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors
Naoki Niikura et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
HER2 Therapy - An Abundance of Riches
William J. Gradishar
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Heterogeneity Maintenance in Glioblastoma: A Social Network
Rudy Bonavia et al.
CANCER RESEARCH (2011)
Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort
Luca Gianni et al.
LANCET (2010)
Loss of HER2 Amplification Following Trastuzumab-Based Neoadjuvant Systemic Therapy and Survival Outcomes
Elizabeth A. Mittendorf et al.
CLINICAL CANCER RESEARCH (2009)
A Naturally Occurring HER2 Carboxy-Terminal Fragment Promotes Mammary Tumor Growth and Metastasis
Kim Pedersen et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
A new model of patient tumor-derived breast cancer Xenografts for preclinical assays
Elisabetta Marangoni et al.
CLINICAL CANCER RESEARCH (2007)
Gene amplification in cancer
Donna G. Albertson
TRENDS IN GENETICS (2006)